Alacrita Life Science Consulting Alacrita Life Science Consulting
  • Our Services
    • Product Development
      • Research & IP Evaluation
      • Preclinical Strategy & Execution
      • Clinical Development
      • Regulatory Affairs
      • CMC Consulting
      • Interim Chief Medical Officer
    • Strategy & Commercialization
      • Opportunity Mapping
      • Business Plans & Fundraising Support
      • New Product Planning
      • Launch Planning
    • Business Development
      • Due Diligence
      • Valuations
      • In-Licensing & Asset Scouting
      • Out-Licensing, Partnering & Deal-making
    • Expert Witness Services
    • By Client Type
      • Biotech
      • Virtual & Semi-Virtual Biotechs
      • Pharmaceutical Companies
      • Investors
      • Research Institutes & Academia
    • By Technology
      • Antibodies, ADCs
      • Cell Therapies
      • Drug Discovery Platforms
      • Gene Therapies
      • Peptides & Proteins
      • Small Molecules
  • Core Team
    • Anthony Walker
    • Simon Turner
    • Alastair Southwell
    • Saadia Basharat
    • Chris Owens
    • Jess Hearn-Messenger
    • Eugene Mironets
    • William (Bill) Slichenmyer
    • Mark Philip
    • Pierre Dodion
    • Nigel Burns
    • Gary Mansfield
    • Christine McCarthy
    • Stuart Hendry
    • Tatiana Gould
  • Consulting Network
  • Resources
    • Case Studies
    • Blog
    • News
    • Whitepapers
  • Careers
  • Contact

Biotech & Pharmaceutical Consulting

business development

These selected case studies illustrate the scope of our work, the level of expertise we’re able to offer, and our consistent record of successful engagements.

  • why us?
  • Case Studies
  • business development
  • All
  • Business Development
  • Product Development
  • Due Diligence
  • Strategy & Commercialization
  • Opportunity Mapping
  • Regulatory Affairs
  • Valuations
  • Clinical Development
  • Research and IP evaluation
  • Asset Scouting
  • Business Strategy
  • New Product Planning
  • Immunotherapy
  • Partnering and deal-making
  • Antibodies, ADCs
  • Small Molecules
  • Cell & Gene Therapy
  • Cell Therapy
  • Discovery Platforms
  • Gene Therapy
  • Peptides & Proteins
  • Pharma Consulting
  • Oncology
  • Launch Planning
  • Partnering & Deal-making
  • Pharma Licensing
  • Cancer Vaccines
  • Preclinical Development
  • Expert Witness
  • Virtual Biotech

Intellectual Property Analysis & Strategy

Due diligence For a financial investor, Alacrita conducted an IP assessment on a late stage cell therapy  investment opportunity. The assessment revealed that the US and EPO patents relied on just...
Learn More

Antibodies

Target Assessment and intellectual property For a mid-cap pharmaceutical company seeking to establish a biologics pipeline through partnership with a mAb development boutique, Alacrita assessed the...
Learn More

Pharmaceutical & Biotech Due Diligence

Alacrita is a leading provider of due diligence to the pharmaceutical industry. Its core team of partners, each of whom has industry experience, are supported by a team of expert, life science...
Learn More
Previous
1 ... 8 9 10 11 12
Content not found

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

  • Strategy and Commercialization Learn more
  • Product Development Learn more
  • Business Development Learn more

© 2023 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

  • Privacy Notice

Alacrita Life Science Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.

Alacrita Life Science Consulting Alacrita Life Science Consulting